Access all 5,000+ company profiles through the Benchmarking Pro Membership. Unlock interactive competitor comparison tools that show you how Acadia Healthcare Company, Inc. stacks up to the competition and put relevant competitor and industry information at your fingertips.
Acadia, Carf, Children’s Behavioral Solutions, Cove Prep, Detroit Behavioral Institute (doi), if The Jason Foundation, Military & Family, Nami, National Association for Behavioral Heathcare, National Association of Addiction Treatment Providers, Resource, Southwood Psychiatric Hospital, Timberline Knolls, Treatment Placement Specialists
Acadia Healthcare Company is a public company headquartered in Tennessee with an estimated 22,500 employees. In the US, the company has a notable market share in at least two industries: Mental Health & Substance Abuse Clinics, Drug & Alcohol Rehabilitation Clinics and Mental Health & Substance Abuse Clinics. Their largest market share is in the Drug & Alcohol Rehabilitation Clinics industry, where they account for an estimated 20.0% of total industry revenue and are considered a Rising Star because they display lower market share, but displaying stronger profit and revenue growth than some of their peers.
Of the 4 core revenue-generating products and services in the Mental Health & Substance Abuse Clinics industry, Acadia Healthcare Company, Inc. offers:
Strengths and weaknesses take into account internal factors, and are based on Acadia Healthcare Company, Inc.'s performance in comparison to its competitors. Opportunities and Threats focus on external influences, and are based on trends and demand in the Mental Health & Substance Abuse Clinics industries
Gain strategic insight and analysis on 700+ in the United States industries
(& thousands of global industries)
BALANCE DATE | 12/31/2018 | 12/31/2019 | 12/31/2020 | 12/31/2021 | 12/31/2022 | 12/31/2023 |
---|---|---|---|---|---|---|
Revenue | 1,904.7 | 2,008.4 | 2,089.9 | 2,314.4 | 2,610.4 | 2,928.7 |
Cost of Revenue | ||||||
Cost of Revenue, Non-Cash | ||||||
Gross Profit | ||||||
00000 |
BALANCE DATE | 12/31/2018 | 12/31/2019 | 12/31/2020 | 12/31/2021 | 12/31/2022 | 12/31/2023 |
---|---|---|---|---|---|---|
Cash and Equivalents | 50.5 | 99.5 | 378.7 | 133.8 | 97.6 | 100.1 |
Short-Term Investments | ||||||
Derivative Assets, Current | ||||||
Restricted Cash and Investments | ||||||
00000 |
BALANCE DATE | 12/31/2018 | 12/31/2019 | 12/31/2020 | 12/31/2021 | 12/31/2022 | 12/31/2023 |
---|---|---|---|---|---|---|
Net Income | -175.5 | 110.1 | -669.2 | 195.6 | 280.0 | N/A |
Income (Loss) From Discontinued Operations | ||||||
Depreciation, Depletion and Amortization | ||||||
Amortization of Financing Costs and Discounts | ||||||
00000 |
IBISWorld provides profiles on thousands of leading companies around the world. Our clients rely on our information and data to stay up-to-date on business and industry trends across all sectors of the economy. This company profile, along with the corresponding competitor and industry data provided, includes thoroughly researched, reliable and current information that will help you to make faster, better business decisions.